MoonLake ImmunotherapeuticsMLTXNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank20
Studio
Year-over-Year Change

Return on equity

Latest
-74.66%
↓ 279% vs avg
Percentile
P20
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
41.64%
Historical baseline
PeriodValueYoY Change
2025-74.66%-180.5%
2024-26.62%-266.4%
2023-7.26%+92.9%
2022-102.20%-122.2%
2021460.66%+570527.4%
2020-0.08%-